AFib for Professionals


Atrial Fibrillation

Cardiac rhythm disorders are common, with AFib - atrial fibrillation (AF) being the most common form of arrhythmia.
The prevalence of AFib in the United States (US) is estimated to rise from ≈5.2 million in 2010 to 12.1 million in 2030. Data from a health insurance claims database covering 5% of the US found the incidence of AFib was estimated at 1.2 million new cases in 2010 and projected it to increase to 2.6 million new cases in 2030. The lifetime risk of AFib in the US is about ≈1 in 3 in Whites and ≈1 in 5 in Blacks. Even with current guideline-based management, AFib patients have stroke, acute coronary syndrome, heart failure, and cardiovascular death at a rate of approximately 5% of patients per year, and 35 to 50% of patients with AFib who receive adequate anticoagulation either receive inpatient therapy or die within 5 years.

Videos on Demand

Close up of patient and doctor taking notes

Updates in Guideline-Directed Antiarrhythmic Medications in AFib

Watch a discussion on AFib management strategies in people with comorbidities and special populations, including pharmacological agents for rhythm and rate control as well as treatment objectives. CE and MOC credits available.

Podcasts

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses

Learn more about Professional Membership